Work

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019

Year: 2021

Type: letter

Source: Mayo Clinic Proceedings

DOI: 10.1016/j.mayocp.2020.12.029

Authors: Zelalem Temesgen, Saad S. Kenderian, Andrew D. Badley

Institution: Mayo Clinic

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3120595496

Cites: 3

Cited by: 1

Related to: 10